Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 118
Filter
2.
ACS Synth Biol ; 8(9): 2059-2068, 2019 09 20.
Article in English | MEDLINE | ID: mdl-31373788

ABSTRACT

Eubacterium limosum is one of the important bacteria in C1 feedstock utilization as well as in human gut microbiota. Although E. limosum has recently garnered much attention and investigation on a genome-wide scale, a bottleneck for systematic engineering in E. limosum is the lack of available genetic tools and an efficient genome editing platform. To overcome this limitation, we here report expanded genetic tools and the CRISPR-Cas9 system. We have developed an inducible promoter system that enables implementation of the CRISPR-Cas9 system to precisely manipulate target genes of the Wood-Ljungdahl pathway with 100% efficiency. Furthermore, we exploited the effectiveness of CRISPR interference to reduce the expression of target genes, exhibiting substantial repression of several genes in the Wood-Ljungdahl pathway and fructose-PTS system. These expanded genetic tools and CRISPR-Cas9 system comprise powerful and widely applicable genetic tools to accelerate functional genomic study and genome engineering in E. limosum.


Subject(s)
CRISPR-Cas Systems/genetics , Eubacterium/genetics , Gene Editing/methods , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Drug Resistance, Bacterial/genetics , Eubacterium/drug effects , Eubacterium/growth & development , Gene Expression Regulation, Bacterial , Genome, Bacterial , Promoter Regions, Genetic , RNA, Guide, Kinetoplastida/metabolism
3.
Gut Microbes ; 10(6): 712-719, 2019.
Article in English | MEDLINE | ID: mdl-30991877

ABSTRACT

Background: A western high fat, high carbohydrate diet has been shown to be associated with decreased gut bacterial diversity and reductions in beneficial bacteria. This gut bacteria dysbiosis could develop in early life and contribute to chronic disease risk such as obesity, type 2 diabetes and non-alcoholic fatty liver disease.Objective: To determine how dietary macronutrients are associated with the relative abundance of gut bacteria in healthy adolescents.Methods: Fifty-two obese participants (12-19 years) from two studies, many who were primarily of Hispanic background, provided fecal samples for 16S rRNA gene sequencing. Dietary macronutrients were assessed using 24-hour diet recalls and body composition was assessed using DEXA. General regression models assuming a negative binomial distribution were used to examine the associations between gut bacteria and dietary fiber, saturated fat, unsaturated fats, protein, added sugar, total sugar and free fructose after adjusting for age, gender, race/ethnicity, body fat percentage, study and caloric intake.Results: The genera Eubacterium (Benjamini-Hochberg (BH) corrected p-value = 0.10) and Streptococcus (BH corrected p-value = 0.04) were inversely associated with dietary fructose intake. There were no other significant associations between abundances of gut microbes and other dietary macronutrients, including fiber, fat, protein, total sugar or added sugar.Conclusions: High dietary fructose was associated with lower abundance of the beneficial microbes Eubacterium and Streptococcus, which are involved with carbohydrate metabolism.


Subject(s)
Dietary Sugars/adverse effects , Eubacterium/growth & development , Fructose/adverse effects , Obesity/etiology , Obesity/microbiology , Streptococcus/growth & development , Adolescent , Bacteria/classification , Bacteria/genetics , Bacteria/isolation & purification , Body Composition , Child , Diet , Dietary Sugars/analysis , Female , Gastrointestinal Microbiome/genetics , Humans , Male , Obesity/pathology , RNA, Ribosomal, 16S/genetics , Young Adult
4.
BMC Genomics ; 19(1): 837, 2018 Nov 23.
Article in English | MEDLINE | ID: mdl-30470174

ABSTRACT

BACKGROUND: Acetogenic bacteria constitute promising biocatalysts for the conversion of CO2/H2 or synthesis gas (H2/CO/CO2) into biofuels and value-added biochemicals. These microorganisms are naturally capable of autotrophic growth via unique acetogenesis metabolism. Despite their biosynthetic potential for commercial applications, a systemic understanding of the transcriptional and translational regulation of the acetogenesis metabolism remains unclear. RESULTS: By integrating genome-scale transcriptomic and translatomic data, we explored the regulatory logic of the acetogenesis to convert CO2 into biomass and metabolites in Eubacterium limosum. The results indicate that majority of genes associated with autotrophic growth including the Wood-Ljungdahl pathway, the reduction of electron carriers, the energy conservation system, and gluconeogenesis were transcriptionally upregulated. The translation efficiency of genes in cellular respiration and electron bifurcation was also highly enhanced. In contrast, the transcriptionally abundant genes involved in the carbonyl branch of the Wood-Ljungdahl pathway, as well as the ion-translocating complex and ATP synthase complex in the energy conservation system, showed decreased translation efficiency. The translation efficiencies of genes were regulated by 5'UTR secondary structure under the autotrophic growth condition. CONCLUSIONS: The results illustrated that the acetogenic bacteria reallocate protein synthesis, focusing more on the translation of genes for the generation of reduced electron carriers via electron bifurcation, rather than on those for carbon metabolism under autotrophic growth.


Subject(s)
Acetates/metabolism , Bacterial Proteins/genetics , Eubacterium/growth & development , Fermentation , Gene Expression Regulation, Bacterial , Autotrophic Processes , Biofuels , Carbon Cycle , Energy Metabolism , Eubacterium/genetics , Eubacterium/metabolism , Gases/analysis , Genome, Bacterial , Transcriptome
5.
Carbohydr Polym ; 199: 482-491, 2018 Nov 01.
Article in English | MEDLINE | ID: mdl-30143153

ABSTRACT

The suitability of artichoke and sunflower by-products as renewable sources of pectic compounds with prebiotic potential was evaluated by studying their ability to modulate the human faecal microbiota in vitro. Bacterial populations and short-chain fatty acid (SCFA) production were measured. Reduction of the molecular weight of artichoke pectin resulted in greater stimulation of the growth of Bifidobacterium, Lactobacillus and Bacteroides/Prevotella, whilst this effect was observed only in Bacteroides/Prevotella for sunflower samples. In contrast, the degree of methoxylation did not have any impact on fermentability properties or SCFA production, regardless of the origin of pectic compounds. Although further in vivo studies should be conducted, either pectin or enzymatically-modified pectin from sunflower and artichoke by-products might be considered as prebiotic candidates for human consumption showing similar ability to promote the in vitro growth of beneficial gut bacteria as compared to well-recognized prebiotics such as inulin or fructo-oligosaccharides.


Subject(s)
Fermentation , Pectins/metabolism , Adult , Bacteroides/growth & development , Bacteroides/metabolism , Bifidobacterium/growth & development , Bifidobacterium/metabolism , Citrus/chemistry , Cynara scolymus/chemistry , Enterococcus/growth & development , Enterococcus/metabolism , Eubacterium/growth & development , Eubacterium/metabolism , Fatty Acids, Volatile/analysis , Feces/microbiology , Female , Gastrointestinal Microbiome/drug effects , Helianthus/chemistry , Humans , Lactobacillus/growth & development , Lactobacillus/metabolism , Male , Pectins/chemistry , Pectins/isolation & purification , Prebiotics , Prevotella/growth & development , Prevotella/metabolism
6.
PLoS One ; 13(7): e0198757, 2018.
Article in English | MEDLINE | ID: mdl-29969462

ABSTRACT

The gut microbiota has recently been recognized to play a role in the pathogenesis of autoimmune liver disease (AILD), mainly primary biliary cholangitis (PBC) and autoimmune hepatitis (AIH). This study aimed to analyze and compare the composition of the oral microbiota of 56 patients with AILD and 15 healthy controls (HCs) and to evaluate its association with salivary immunological biomarkers and gut microbiota. The subjects included 39 patients with PBC and 17 patients with AIH diagnosed at our hospital. The control population comprised 15 matched HCs. Salivary and fecal samples were collected for analysis of the microbiome by terminal restriction fragment length polymorphism of 16S rDNA. Correlations between immunological biomarkers measured by Bio-Plex assay (Bio-Rad) and the oral microbiomes of patients with PBC and AIH were assessed. Patients with AIH showed a significant increase in Veillonella with a concurrent decrease in Streptococcus in the oral microbiota compared with the HCs. Patients with PBC showed significant increases in Eubacterium and Veillonella and a significant decrease in Fusobacterium in the oral microbiota compared with the HCs. Immunological biomarker analysis showed elevated levels of inflammatory cytokines (IL-1ß, IFN-γ, TNF-α, IL-8) and immunoglobulin A in the saliva of patients with AILD. The relative abundance of Veillonella was positively correlated with the levels of IL-1ß, IL-8 and immunoglobulin A in saliva and the relative abundance of Lactobacillales in feces. Dysbiosis of the oral microbiota is associated with inflammatory responses and reflects changes in the gut microbiota of patients with AILD. Dysbiosis may play an important role in the pathogenesis of AILD.


Subject(s)
Dysbiosis/immunology , Hepatitis, Autoimmune/immunology , Liver Cirrhosis, Biliary/immunology , Microbiota/immunology , Mouth/microbiology , Aged , Case-Control Studies , Dysbiosis/diagnosis , Dysbiosis/pathology , Eubacterium/growth & development , Eubacterium/immunology , Eubacterium/isolation & purification , Feces/microbiology , Female , Fusobacterium/growth & development , Fusobacterium/immunology , Fusobacterium/isolation & purification , Gene Expression , Hepatitis, Autoimmune/diagnosis , Hepatitis, Autoimmune/pathology , Humans , Interferon-gamma/genetics , Interferon-gamma/immunology , Interleukin-1beta/genetics , Interleukin-1beta/immunology , Interleukin-8/genetics , Interleukin-8/immunology , Lactobacillales/growth & development , Lactobacillales/immunology , Lactobacillales/isolation & purification , Liver Cirrhosis, Biliary/diagnosis , Liver Cirrhosis, Biliary/pathology , Male , Middle Aged , Saliva/microbiology , Streptococcus/growth & development , Streptococcus/immunology , Streptococcus/isolation & purification , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/immunology , Veillonella/growth & development , Veillonella/immunology , Veillonella/isolation & purification
7.
Microb Ecol ; 75(1): 228-238, 2018 Jan.
Article in English | MEDLINE | ID: mdl-28721502

ABSTRACT

Mucus production is initiated before birth and provides mucin glycans to the infant gut microbiota. Bifidobacteria are the major bacterial group in the feces of vaginally delivered and breast milk-fed infants. Among the bifidobacteria, only Bifidobacterium bifidum is able to degrade mucin and to release monosaccharides which can be used by other gut microbes colonizing the infant gut. Eubacterium hallii is an early occurring commensal that produces butyrate and propionate from fermentation metabolites but that cannot degrade complex oligo- and polysaccharides. We aimed to demonstrate that mucin cross-feeding initiated by B. bifidum enables growth and metabolite formation of E. hallii leading to short-chain fatty acid (SCFA) formation. Growth and metabolite formation of co-cultures of B. bifidum, of Bifidobacterium breve or Bifidobacterium infantis, which use mucin-derived hexoses and fucose, and of E. hallii were determined. Growth of E. hallii in the presence of lactose and mucin monosaccharides was tested. In co-culture fermentations, the presence of B. bifidum enabled growth of the other strains. B. bifidum/B. infantis co-cultures yielded acetate, formate, and lactate while co-cultures of B. bifidum and E. hallii formed acetate, formate, and butyrate. In three-strain co-cultures, B. bifidum, E. hallii, and B. breve or B. infantis produced up to 16 mM acetate, 5 mM formate, and 4 mM butyrate. The formation of propionate (approximately 1 mM) indicated cross-feeding on fucose. Lactose, galactose, and GlcNAc were identified as substrates of E. hallii. This study shows that trophic interactions of bifidobacteria and E. hallii lead to the formation of acetate, butyrate, propionate, and formate, potentially contributing to intestinal SCFA formation with potential benefits for the host and for microbial colonization of the infant gut. The ratios of SCFA formed differed depending on the microbial species involved in mucin cross-feeding.


Subject(s)
Bifidobacterium/metabolism , Eubacterium/metabolism , Mucins/metabolism , Adult , Animals , Bifidobacterium/growth & development , Bifidobacterium/isolation & purification , Breast Feeding , Eubacterium/growth & development , Eubacterium/isolation & purification , Fatty Acids, Volatile/metabolism , Feces/microbiology , Female , Fermentation , Gastrointestinal Microbiome , Humans , Infant , Intestines/microbiology , Male
8.
Biomed Res Int ; 2017: 4969076, 2017.
Article in English | MEDLINE | ID: mdl-29457028

ABSTRACT

Ruminants derived products have a prominent role in diets and economy worldwide; therefore, the capability to control the rumen microbial ecosystem, for ameliorating their quality, is of fundamental importance in the livestock sector. The aim of this study was to evaluate the effect of dietary supplementation with chestnut and quebracho tannins on microbial community and fatty acid profile, in the rumen fluid of dairy ewes. Multivariate analysis of PCR-DGGE profiles of rumen microbial communities showed a correlation among the presence of chestnut or quebracho in the diet, the specific Butyrivibrio group DGGE profiles, the increase in 18:3 cis9, cis12, and cis15; 18:2 cis9 and cis12; 18:2 cis9 and trans11; 18:2 trans11 and cis15; and 18:1 trans11 content, and the decrease in 18:0 concentration. Phylogenetic analysis of DGGE band sequences revealed the presence of bacteria representatives related to the genera Hungatella, Ruminococcus, and Eubacterium and unclassified Lachnospiraceae family members, suggesting that these taxa could be affected by tannins presence in the diets. The results of this study showed that tannins from chestnut and quebracho can reduce the biohydrogenation of unsaturated fatty acids through changes in rumen microbial communities.


Subject(s)
Dietary Supplements , Rumen/microbiology , Tannins/administration & dosage , Aesculus/chemistry , Animal Feed , Animals , Digestion/drug effects , Eubacterium/drug effects , Eubacterium/genetics , Eubacterium/growth & development , Fatty Acids, Unsaturated , Female , Lactation/drug effects , Phylogeny , Rumen/drug effects , Ruminococcus/drug effects , Ruminococcus/genetics , Ruminococcus/growth & development , Sheep , Tannins/chemistry
9.
Microbiome ; 4: 12, 2016 Mar 14.
Article in English | MEDLINE | ID: mdl-26975510

ABSTRACT

BACKGROUND: Clostridium difficile infection (CDI) is the leading infectious cause of nosocomial diarrhea. Hospitalized patients are at increased risk of developing CDI because they are exposed to C. difficile spores through contact with the hospital environment and often receive antibiotics and other medications that can disrupt the integrity of the indigenous intestinal microbiota and impair colonization resistance. Using whole metagenome shotgun sequencing, we examined the diversity and composition of the fecal microbiota in a prospective cohort study of 98 hospitalized patients. RESULTS: Four patients had asymptomatic C. difficile colonization, and four patients developed CDI. We observed dramatic shifts in the structure of the gut microbiota during hospitalization. In contrast to CDI cases, asymptomatic patients exhibited elevated relative abundance of potentially protective bacterial taxa in their gut at the onset of C. difficile colonization. Use of laxatives was associated with significant reductions in the relative abundance of Clostridium and Eubacterium; species within these genera have previously been shown to enhance resistance to CDI via the production of secondary bile acids. Cephalosporin and fluoroquinolone exposure decreased the frequency of Clostridiales Family XI Incertae Sedis, a bacterial family that has been previously associated with decreased CDI risk. CONCLUSIONS: This study underscores the detrimental impact of antibiotics as well as other medications, particularly laxatives, on the intestinal microbiota and suggests that co-colonization with key bacterial taxa may prevent C. difficile overgrowth or the transition from asymptomatic C. difficile colonization to CDI.


Subject(s)
Anti-Bacterial Agents/adverse effects , Clostridioides difficile/pathogenicity , Cross Infection/microbiology , Diarrhea/microbiology , Enterocolitis, Pseudomembranous/microbiology , Gastrointestinal Microbiome/genetics , Metagenome , Aged , Bile Acids and Salts/biosynthesis , Cephalosporins/adverse effects , Clostridioides difficile/drug effects , Clostridioides difficile/growth & development , Cross Infection/pathology , Diarrhea/etiology , Diarrhea/pathology , Enterocolitis, Pseudomembranous/etiology , Enterocolitis, Pseudomembranous/pathology , Eubacterium/drug effects , Eubacterium/growth & development , Eubacterium/pathogenicity , Female , Fluoroquinolones/adverse effects , Humans , Laxatives/adverse effects , Male , Middle Aged , Prospective Studies
10.
BMC Biol ; 14: 3, 2016 Jan 11.
Article in English | MEDLINE | ID: mdl-26754945

ABSTRACT

BACKGROUND: Dietary intake of specific non-digestible carbohydrates (including prebiotics) is increasingly seen as a highly effective approach for manipulating the composition and activities of the human gut microbiota to benefit health. Nevertheless, surprisingly little is known about the global response of the microbial community to particular carbohydrates. Recent in vivo dietary studies have demonstrated that the species composition of the human faecal microbiota is influenced by dietary intake. There is now potential to gain insights into the mechanisms involved by using in vitro systems that produce highly controlled conditions of pH and substrate supply. RESULTS: We supplied two alternative non-digestible polysaccharides as energy sources to three different human gut microbial communities in anaerobic, pH-controlled continuous-flow fermentors. Community analysis showed that supply of apple pectin or inulin resulted in the highly specific enrichment of particular bacterial operational taxonomic units (OTUs; based on 16S rRNA gene sequences). Of the eight most abundant Bacteroides OTUs detected, two were promoted specifically by inulin and six by pectin. Among the Firmicutes, Eubacterium eligens in particular was strongly promoted by pectin, while several species were stimulated by inulin. Responses were influenced by pH, which was stepped up, and down, between 5.5, 6.0, 6.4 and 6.9 in parallel vessels within each experiment. In particular, several experiments involving downshifts to pH 5.5 resulted in Faecalibacterium prausnitzii replacing Bacteroides spp. as the dominant sequences observed. Community diversity was greater in the pectin-fed than in the inulin-fed fermentors, presumably reflecting the differing complexity of the two substrates. CONCLUSIONS: We have shown that particular non-digestible dietary carbohydrates have enormous potential for modifying the gut microbiota, but these modifications occur at the level of individual strains and species and are not easily predicted a priori. Furthermore, the gut environment, especially pH, plays a key role in determining the outcome of interspecies competition. This makes it crucial to put greater effort into identifying the range of bacteria that may be stimulated by a given prebiotic approach. Both for reasons of efficacy and of safety, the development of prebiotics intended to benefit human health has to take account of the highly individual species profiles that may result.


Subject(s)
Dietary Fiber/microbiology , Gastrointestinal Microbiome , Inulin/metabolism , Pectins/metabolism , Bacteroides/growth & development , Bacteroides/isolation & purification , Bioreactors , Dietary Fiber/metabolism , Eubacterium/growth & development , Eubacterium/isolation & purification , Fatty Acids/metabolism , Fermentation , Firmicutes/growth & development , Firmicutes/isolation & purification , Humans , Hydrogen-Ion Concentration , RNA, Ribosomal, 16S/analysis
11.
Appl Environ Microbiol ; 81(22): 7767-81, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26319874

ABSTRACT

Arabinoxylan oligosaccharides (AXOS) are a promising class of prebiotics that have the potential to stimulate the growth of bifidobacteria and the production of butyrate in the human colon, known as the bifidogenic and butyrogenic effects, respectively. Although these dual effects of AXOS are considered beneficial for human health, their underlying mechanisms are still far from being understood. Therefore, this study investigated the metabolic interactions between Bifidobacterium longum subsp. longum NCC2705 (B. longum NCC2705), an acetate producer and arabinose substituent degrader of AXOS, and Eubacterium rectale ATCC 33656, an acetate-converting butyrate producer. Both strains belong to prevalent species of the human colon microbiota. The strains were grown on AXOS during mono- and coculture fermentations, and their growth, AXOS consumption, metabolite production, and expression of key genes were monitored. The results showed that the growth of both strains and gene expression in both strains were affected by cocultivation and that these effects could be linked to changes in carbohydrate consumption and concomitant metabolite production. The consumption of the arabinose substituents of AXOS by B. longum NCC2705 with the concomitant production of acetate allowed E. rectale ATCC 33656 to produce butyrate (by means of a butyryl coenzyme A [CoA]:acetate CoA-transferase), explaining the butyrogenic effect of AXOS. Eubacterium rectale ATCC 33656 released xylose from the AXOS substrate, which favored the B. longum NCC2705 production of acetate, explaining the bifidogenic effect of AXOS. Hence, those interactions represent mutual cross-feeding mechanisms that favor the coexistence of bifidobacterial strains and butyrate producers in the same ecological niche. In conclusion, this study provides new insights into the bifidogenic and butyrogenic effects of AXOS.


Subject(s)
Bacterial Proteins/genetics , Bifidobacterium/genetics , Eubacterium/genetics , Oligosaccharides/metabolism , Bacterial Proteins/metabolism , Bifidobacterium/growth & development , Bifidobacterium/metabolism , Eubacterium/growth & development , Eubacterium/metabolism , Gene Expression , Reverse Transcriptase Polymerase Chain Reaction , Xylans/metabolism
12.
Mol Microbiol ; 95(2): 209-30, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25388295

ABSTRACT

Eubacterium rectale is a prominent human gut symbiont yet little is known about the molecular strategies this bacterium has developed to acquire nutrients within the competitive gut ecosystem. Starch is one of the most abundant glycans in the human diet, and E. rectale increases in vivo when the host consumes a diet rich in resistant starch, although it is not a primary degrader of this glycan. Here we present the results of a quantitative proteomics study in which we identify two glycoside hydrolase 13 family enzymes, and three ABC transporter solute-binding proteins that are abundant during growth on starch and, we hypothesize, work together at the cell surface to degrade starch and capture the released maltooligosaccharides. EUR_21100 is a multidomain cell wall anchored amylase that preferentially targets starch polysaccharides, liberating maltotetraose, whereas the membrane-associated maltogenic amylase EUR_01860 breaks down maltooligosaccharides longer than maltotriose. The three solute-binding proteins display a range of glycan-binding specificities that ensure the capture of glucose through maltoheptaose and some α1,6-branched glycans. Taken together, we describe a pathway for starch utilization by E. rectale DSM 17629 that may be conserved among other starch-degrading Clostridium cluster XIVa organisms in the human gut.


Subject(s)
Eubacterium/genetics , Eubacterium/metabolism , Starch/metabolism , ATP-Binding Cassette Transporters/genetics , ATP-Binding Cassette Transporters/metabolism , Carbohydrate Metabolism , Cell Membrane/metabolism , Cell Wall/metabolism , Chromatography, Thin Layer , Eubacterium/growth & development , Glycoside Hydrolases/genetics , Glycoside Hydrolases/metabolism , Maltose/analogs & derivatives , Maltose/metabolism , Mass Spectrometry , Microarray Analysis , Oligosaccharides/metabolism , Proteomics , Trisaccharides/metabolism
13.
Bioresour Technol ; 169: 637-643, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25105269

ABSTRACT

This study proposed a submerged hollow fibre membrane bioreactor (HFMBR) system capable of achieving high carbon monoxide (CO) mass transfer for applications in microbial synthesis gas conversion systems. Hydrophobic polyvinylidene fluoride (PVDF) membrane fibres were used to fabricate a membrane module, which was used for pressurising CO in water phase. Pressure through the hollow fibre lumen (P) and membrane surface area per unit working volume of the liquid (A(S)/V(L)) were used as controllable parameters to determine gas-liquid volumetric mass transfer coefficient (k(L)a) values. We found a k(L)a of 135.72 h(-1) when P was 93.76 kPa and AS/VL was fixed at 27.5m(-1). A higher k(L)a of 155.16 h(-1) was achieved by increasing AS/VL to 62.5m(-1) at a lower P of 37.23 kPa. Practicality of HFMBR to support microbial growth and organic product formation was assessed by CO/CO2 fermentation using Eubacterium limosum KIST612.


Subject(s)
Biofuels/microbiology , Bioreactors/microbiology , Carbon Monoxide/chemistry , Eubacterium/metabolism , Fermentation , Membranes, Artificial , Pressure , Carbon Dioxide/metabolism , Diffusion , Eubacterium/growth & development
14.
Bioresour Technol ; 151: 69-77, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24211485

ABSTRACT

Syngas fermentation to fuels is a technology on the verge of commercialization. Low cost of fermentation medium is important for process feasibility. The use of corn steep liquor (CSL) instead of yeast extract (YE) in Alkalibaculum bacchi strain CP15 bottle fermentations reduced the medium cost by 27% and produced 78% more ethanol. When continuous fermentation was performed in a 7-L fermentor, 6g/L ethanol was obtained in the YE and YE-free media. When CSL medium was used in continuous fermentation, the maximum produced concentrations of ethanol, n-propanol and n-butanol were 8 g/L, 6 g/L and 1 g/L, respectively. n-Propanol and n-butanol were not typical products of strain CP15. A 16S rRNA gene-based survey revealed a mixed culture in the fermentor dominated by A. bacchi strain CP15 (56%) and Clostridium propionicum (34%). The mixed culture presents an opportunity for higher alcohols production from syngas.


Subject(s)
1-Butanol/metabolism , 1-Propanol/metabolism , Ethanol/metabolism , Fermentation , Gases/metabolism , Acetic Acid/metabolism , Bioreactors/microbiology , Carbon/metabolism , Culture Media/pharmacology , Eubacterium/drug effects , Eubacterium/growth & development , Eubacterium/metabolism , Fermentation/drug effects , Hydrogen-Ion Concentration/drug effects
15.
J Biotechnol ; 167(4): 370-6, 2013 Sep 20.
Article in English | MEDLINE | ID: mdl-23892193

ABSTRACT

Technical scale (≥5l) cultivations of shear stress sensitive microorganisms are often difficult to perform, as common bioreactors are usually designed to maximize the oxygen input into the culture medium. This is achieved by mechanical stirrers, causing high shear stress. Examples for shear stress sensitive microorganisms, for which no specific cultivation systems exist, are many anaerobic bacteria and fungi, such as basidiomycetes. In this work a disposable bag bioreactor developed for cultivation of mammalian cells was investigated to evaluate its potential to cultivate shear stress sensitive anaerobic Eubacterium ramulus and shear stress sensitive basidiomycetes Flammulina velutipes and Pleurotus sapidus. All cultivations were compared with conventional stainless steel stirred tank reactors (STR) cultivations. Good growth of all investigated microorganisms cultivated in the bag reactor was found. E. ramulus showed growth rates of µ=0.56 h⁻¹ (bag) and µ=0.53 h⁻¹ (STR). Differences concerning morphology, enzymatic activities and growth in fungal cultivations were observed. In the bag reactor growth in form of small, independent pellets was observed while STR cultivations showed intense aggregation. F. velutipes reached higher biomass concentrations (21.2 g l⁻¹ DCW vs. 16.8 g l⁻¹ DCW) and up to 2-fold higher peptidolytic activities in comparison to cell cultivation in stirred tank reactors.


Subject(s)
Bioreactors , Eubacterium/growth & development , Flammulina/growth & development , Pleurotus/growth & development , Anaerobiosis , Biomass , Culture Media , Eubacterium/enzymology , Flammulina/enzymology , Industrial Microbiology/methods , Pleurotus/enzymology , Reproducibility of Results , Stress, Physiological
16.
Zebrafish ; 10(2): 194-8, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23530761

ABSTRACT

The zebrafish has become increasingly popular for microbiological research. It has been used as an infection model for a variety of pathogens, and is also emerging as a tool for studying interactions between a host and its resident microbial communities. The mouse microbiota has been transplanted into the zebrafish gut, but to our knowledge, there has been no attempt to introduce a bacterial community derived from the human gut. We explored two methods for colonizing the developing gut of 5-day-old germ-free zebrafish larvae with a defined anaerobic microbial community derived from a single human fecal sample. Both environmental exposure (static immersion) and direct microinjection into the gut resulted in the establishment of two species-Lactobacillus paracasei and Eubacterium limosum-from a community of 30 strains consisting of 22 anaerobic species. Of particular interest is E. limosum, which, as a strict anaerobe, represents a group of bacteria which until now have not been shown to colonize the developing zebrafish gut. Our success here indicates that further investigation of zebrafish as a tool for studying human gut microbial communities is warranted.


Subject(s)
Bacteria, Anaerobic/isolation & purification , Gastrointestinal Tract/microbiology , Germ-Free Life , Models, Animal , Zebrafish/microbiology , Animals , Bacteria, Anaerobic/genetics , Bacteria, Anaerobic/growth & development , Bacteria, Anaerobic/metabolism , Eubacterium/genetics , Eubacterium/growth & development , Eubacterium/isolation & purification , Eubacterium/metabolism , Feces/microbiology , Humans , Immersion , Lactobacillus/genetics , Lactobacillus/growth & development , Lactobacillus/isolation & purification , Lactobacillus/metabolism , Larva/growth & development , Larva/microbiology , Microinjections , Zebrafish/growth & development
17.
ISME J ; 7(2): 269-80, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23038174

ABSTRACT

The involvement of the gut microbiota in metabolic disorders, and the ability of whole grains to affect both host metabolism and gut microbial ecology, suggest that some benefits of whole grains are mediated through their effects on the gut microbiome. Nutritional studies that assess the effect of whole grains on both the gut microbiome and human physiology are needed. We conducted a randomized cross-over trial with four-week treatments in which 28 healthy humans consumed a daily dose of 60 g of whole-grain barley (WGB), brown rice (BR), or an equal mixture of the two (BR+WGB), and characterized their impact on fecal microbial ecology and blood markers of inflammation, glucose and lipid metabolism. All treatments increased microbial diversity, the Firmicutes/Bacteroidetes ratio, and the abundance of the genus Blautia in fecal samples. The inclusion of WGB enriched the genera Roseburia, Bifidobacterium and Dialister, and the species Eubacterium rectale, Roseburia faecis and Roseburia intestinalis. Whole grains, and especially the BR+WGB treatment, reduced plasma interleukin-6 (IL-6) and peak postprandial glucose. Shifts in the abundance of Eubacterium rectale were associated with changes in the glucose and insulin postprandial response. Interestingly, subjects with greater improvements in IL-6 levels harbored significantly higher proportions of Dialister and lower abundance of Coriobacteriaceae. In conclusion, this study revealed that a short-term intake of whole grains induced compositional alterations of the gut microbiota that coincided with improvements in host physiological measures related to metabolic dysfunctions in humans.


Subject(s)
Diet , Edible Grain , Gastrointestinal Tract/microbiology , Metagenome , Adult , Bacteroidetes/growth & development , Bifidobacterium/growth & development , Biodiversity , Biomarkers/blood , Blood Glucose/analysis , Cross-Over Studies , Eubacterium/growth & development , Feces/microbiology , Female , Gastrointestinal Tract/immunology , Gastrointestinal Tract/metabolism , Hordeum , Humans , Inflammation/blood , Insulin/blood , Interleukin-6/blood , Male , Oryza , Young Adult
18.
Braz. j. microbiol ; 43(3): 931-937, July-Sept. 2012. graf, tab
Article in English | LILACS | ID: lil-656655

ABSTRACT

The aim of the present study was to evaluate the frequency of detection of Mogibacterium timidum in subgingival samples of subjects with generalized aggressive periodontitis (GAgP) and uncontrolled diabetic and non-diabetic subjects with generalized chronic periodontitis (GChP). 48 patients with GAgP, 50 non-diabetic and 39 uncontrolled (glycated hemoglobin >7%) type 2 diabetic subjects with GChP were enrolled in this study. Subgingival biofilm were collected from deep pockets (probing depth > 7 mm). After DNA extraction, M. timidum was detected by Nested Polymerase Chain Reaction and chi-square test was used to data analysis (p>0.05). There were no differences in the frequency of detection of M. timidum between subjects with GAgP (35%) and non-diabetic subjects with GChP (40%) (p>0.05). The frequency of detection of M. timidum was significantly higher in deep pockets of diabetic subjects with GChP (56%) when compared to GAgP (p<0.05), but similar to non-diabetic subjects with GChP (p>0.05). The frequency of detection of M. timidum was higher in subjects GChP presenting uncontrolled type 2 diabetes mellitus, when compared to GAgP subjects.


Subject(s)
Humans , Biodiversity , Dental Plaque , Diabetes Mellitus , Eubacterium/growth & development , Gram-Positive Bacterial Infections , Periodontitis , Methods , Patients
19.
Arch Oral Biol ; 57(8): 1041-7, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22405584

ABSTRACT

OBJECTIVE: To investigate the antimicrobial activity of the bacteriocin-producing strain Streptococcus salivarius K12 against several bacteria involved in halitosis. DESIGN: The inhibitory activity of S. salivarius K12 against Solobacterium moorei CCUG39336, four clinical S. moorei isolates, Atopobium parvulum ATCC33793 and Eubacterium sulci ATCC35585 was examined by a deferred antagonism test. Eubacterium saburreum ATCC33271 and Parvimonas micra ATCC33270, which have been tested in previous studies, served as positive controls, and the Gram-negative strain Bacteroides fragilis ZIB2800 served as a negative control. Additionally, the occurrence of resistance in S. moorei CCUG39336 to S. salivarius K12 was analysed by either direct plating or by passage of S. moorei CCUG39336 on chloroform-inactived S. salivarius K12-containing agar plates. RESULTS: S. salivarius K12 suppressed the growth of all Gram-positive bacteria tested, but the extent to which the bacteria were inhibited varied. E. sulci ATCC35585 was the most sensitive strain, while all five S. moorei isolates were inhibited to a lesser extent. Natural resistance seems to be very low in S. moorei CCUG39336, and there was only a slight decrease in sensitivity after exposure to S. salivarius K12 over 10 passages. CONCLUSION: Our studies demonstrate that S. salivarius K12 has antimicrobial activity against bacteria involved in halitosis. This strain might be an interesting and valuable candidate for the development of an antimicrobial therapy for halitosis.


Subject(s)
Actinobacteria/growth & development , Halitosis/microbiology , Halitosis/prevention & control , Probiotics/pharmacology , Streptococcus/physiology , Actinobacteria/isolation & purification , Administration, Oral , Bacterial Proteins/pharmacology , Bacteriocins/pharmacology , Eubacterium/growth & development , Eubacterium/isolation & purification , Gram-Positive Bacteria/growth & development , Gram-Positive Bacteria/isolation & purification , Humans , In Vitro Techniques , Linear Models , Microbial Sensitivity Tests
20.
FEMS Microbiol Ecol ; 79(3): 685-96, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22092917

ABSTRACT

The mucus layer in the colon, acting as a barrier to prevent invasion of pathogens, is thinner and discontinuous in patients with ulcerative colitis (UC). A recent developed in vitro dynamic gut model, the M-SHIME, was used to compare long-term colonization of the mucin layer by the microbiota from six healthy volunteers (HV) and six UC patients and thus distinguish the mucin adhered from the luminal microbiota. Although under the same nutritional conditions, short-chain fatty acid production by the luminal communities from UC patients showed a tendency toward a lower butyrate production. A more in-depth community analysis of those microbial groups known to produce butyrate revealed that the diversity of the Clostridium coccoides/Eubacterium rectale and Clostridium leptum group, and counts of Faecalibacterium prausnitzii were lower in the luminal fractions of the UC samples. Counts of Roseburia spp. were lower in the mucosal fractions of the UC samples. qPCR analysis for butyryl-CoA:acetate CoA transferase, responsible for butyrate production, displayed a lower abundance in both the luminal and mucosal fractions of the UC samples. The M-SHIME model revealed depletion in butyrate producing microbial communities not restricted to the luminal but also in the mucosal samples from UC patients compared to HV.


Subject(s)
Clostridium/physiology , Colitis, Ulcerative/microbiology , Eubacterium/physiology , Mucins/metabolism , Acyl Coenzyme A/genetics , Acyl Coenzyme A/metabolism , Adult , Aged , Butyrates/metabolism , Clostridium/growth & development , Coenzyme A-Transferases/genetics , Coenzyme A-Transferases/metabolism , Colitis, Ulcerative/metabolism , Eubacterium/growth & development , Fatty Acids, Volatile/metabolism , Female , Gastrointestinal Tract/microbiology , Humans , Intestinal Mucosa/microbiology , Male , Middle Aged , Models, Biological
SELECTION OF CITATIONS
SEARCH DETAIL
...